share_log

HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $3 Price Target

Moomoo 24/7 ·  Mar 14 07:31

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cadrenal Therapeutics (NASDAQ:CVKD) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment